90 related articles for article (PubMed ID: 20136565)
1. After 50 years of ethinylestradiol, another oestrogen in combined oral contraceptives.
Alsina JC
Eur J Contracept Reprod Health Care; 2010 Feb; 15(1):1-3. PubMed ID: 20136565
[No Abstract] [Full Text] [Related]
2. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
Oettel M; Carol W; Gräser T; Klinger G; Mellinger U; Moore C; Schindler AE; Winkler UH
Zentralbl Gynakol; 1997; 119(12):597-606. PubMed ID: 9483810
[TBL] [Abstract][Full Text] [Related]
3. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Kuhl H
Contraception; 2008 Nov; 78(5):384-91. PubMed ID: 18929735
[TBL] [Abstract][Full Text] [Related]
4. [Influence of a new monophasic oral contraceptive on body metabolism].
Radowicki S; Skórzewska K; Borakowska B
Ginekol Pol; 2003 Sep; 74(9):1002-7. PubMed ID: 14674159
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of obesity in a 22-year-old female patient].
Iwen A; Lehnert H
Dtsch Med Wochenschr; 2010 Oct; 135(41):2041-2. PubMed ID: 20925014
[No Abstract] [Full Text] [Related]
6. Oral contraceptives according to the normophasic principle.
Borglin NE; Klottrup P
Arzneimittelforschung; 1978; 28(12):2354-7. PubMed ID: 582954
[TBL] [Abstract][Full Text] [Related]
7. [A combiphasic oral contraceptive containing ethinylestradiol and desogestrel].
Poulsen HK
Ugeskr Laeger; 1995 Aug; 157(32):4473-5. PubMed ID: 7483033
[No Abstract] [Full Text] [Related]
8. Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.
Sänger N; Stahlberg S; Manthey T; Mittmann K; Mellinger U; Lange E; Kuhl H; Wiegratz I
Contraception; 2008 Jun; 77(6):420-5. PubMed ID: 18477491
[TBL] [Abstract][Full Text] [Related]
9. Ethinylestradiol/dienogest in oral contraception.
Pérez-Campos EF
Drugs; 2010 Apr; 70(6):681-9. PubMed ID: 20394455
[TBL] [Abstract][Full Text] [Related]
10. Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in Poland.
Golbs S; Domhardt R; Radowicky S; Kałuzny Z; Wisser KH; Zimmermann T
Methods Find Exp Clin Pharmacol; 2002 Nov; 24(9):585-92. PubMed ID: 12616705
[TBL] [Abstract][Full Text] [Related]
11. Risk of venous thrombosis varies with different types of combined oral contraceptives.
DeSancho MT
Evid Based Med; 2014 Apr; 19(2):e11. PubMed ID: 24288174
[No Abstract] [Full Text] [Related]
12. ACP Journal Club. Review: Combined oral contraceptives are associated with venous thrombosis.
Harper DM; Wilfling LE; Blanner CF
Ann Intern Med; 2013 Dec; 159(12):JC12. PubMed ID: 24343405
[No Abstract] [Full Text] [Related]
13. Effect of ethinylestradiol dose and progestagen in combined oral contraceptives on plasma sex hormone-binding globulin levels in premenopausal women.
Stegeman BH; Raps M; Helmerhorst FM; Vos HL; van Vliet HA; Rosendaal FR; van Hylckama Vlieg A
J Thromb Haemost; 2013 Jan; 11(1):203-5. PubMed ID: 23122048
[No Abstract] [Full Text] [Related]
14. [The effect of contraceptive with 20 ug ethinylestradiol and 150 ug desogestrel on some acute phase proteins].
Uchikova E; Batashki I; Milchev N; Mateva N; Markova D; Gŭrova A
Akush Ginekol (Sofiia); 2006; 45(2):39-43. PubMed ID: 16637303
[TBL] [Abstract][Full Text] [Related]
15. [The behavior of cytoplasmic progesterone receptors in the cycling endometrium and the effect of hormonal contraceptives].
Carol W; Jäger R; Martin P; Möller U
Zentralbl Gynakol; 1989; 111(12):793-9. PubMed ID: 2763749
[TBL] [Abstract][Full Text] [Related]
16. Effect of four oral contraceptives on hemostatic parameters.
Wiegratz I; Lee JH; Kutschera E; Winkler UH; Kuhl H
Contraception; 2004 Aug; 70(2):97-106. PubMed ID: 15288212
[TBL] [Abstract][Full Text] [Related]
17. The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism.
Mueck AO; Seeger H; Gräser T; Oettel M; Lippert TH
Horm Metab Res; 2001 Dec; 33(12):744-7. PubMed ID: 11753761
[TBL] [Abstract][Full Text] [Related]
18. [Acceptability and secondary effects of a new oral contraceptive containing ethinylestradiol and gestodene].
Cremer P; Vekemans M
Rev Med Brux; 1987 Nov; 8(9):440-6. PubMed ID: 3423522
[No Abstract] [Full Text] [Related]
19. Endometrial safety of a novel monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen over six cycles.
Rabe T; Hartschuh E; Wahlstrom T; Höschen K; König S
Contraception; 2010 Oct; 82(4):358-65. PubMed ID: 20851230
[TBL] [Abstract][Full Text] [Related]
20. Rationale for new oral contraceptive dosing.
Williams JK
Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
